Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01841840 · ClinicalTrials.gov registry record · NA

The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
11
Enrollment target

NCT01841840: Completed NA study, sponsored by Florida State University.

NCT01841840 is a NA study that has completed, run by Florida State University. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01841840, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

Stroke is the third leading cause of death in the United States. Of those who are affected by stroke, a third becomes permanently disabled. Risk factors for stroke include, but are not limited to, advancing age, physical inactivity, arterial stiffness, and most commonly, high blood pressure. Stroke is a major form of a much boarder problem, cardiovascular disease (CVD). CVD is considered the primary cause of death in the US. Interestingly, increased arterial stiffness of elastic arteries (carotid and aorta) has been shown to be strongly correlated to CVD and stroke. Increased arterial stiffness is considered an independent risk for the development of CVD and stroke. Hence, arterial stiffness has been suggested as a potential therapeutic target for CVD and more specifically stroke. Recently, whole-body vibration (WBV) exercise has been proposed as a new and effective method to improve muscle mass and muscle strength in younger and older individuals. It is known that systemic arterial stiffness decreased 40 min after a single WBV session in healthy men. In our laboratory, we have shown that leg arterial stiffness decreases after a session of WBV. Taken together, this data seems to suggest WBV may be used as a viable way to decrease arterial stiffness. Special populations, such as post-stroke patients, may be unwilling or unable to perform WBV exercise so an inactive form of exercise (vibration) therapy is needed. Passive vibration (PV), allows patients to lie in an inactive, supine position, with their legs placed onto the vibration plate. This exposes the lower limbs to continuous vibration without performing voluntary muscle contraction. PV has been shown to increase skin blood flow on the vibrated extremity through vasodilation in healthy individuals and type 2 diabetics. Previous work in our laboratory has demonstrated that a 10-min session of PV on the legs decreases augmentation index (AIx) , a marker of pressure wave reflection, as well as leg and systemic PW

Primary Outcome

Non-invasive measures of brachial blood pressure

Interventions

  • OTHER Low-Frequency Passive Vibration
  • OTHER High-Frequency Pasive Vibration

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2012-01
Est. Completion 2012-07
Phase NA
Florida State University

219 total trials

What the finished NCT01841840 record still lists

NCT01841840 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Low-Frequency Passive Vibration is the first listed.

NCT01841840 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01841840 about?

NCT01841840 is a clinical study titled "The Acute Effects of Passive Vibration on Cardiovascular Function in Individuals With Stroke". Stroke is the third leading cause of death in the United States. Of those who are affected by stroke, a third becomes permanently disabled. Risk factors for stroke include, but are not limited to, advancing age, physical inactivity, arterial stiffness, and most commonly, high blood pressure. Stroke ...

What is the current status of trial NCT01841840?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2012-01. Estimated completion is 2012-07.

What interventions are being tested in trial NCT01841840?

The interventions under investigation include: Low-Frequency Passive Vibration (OTHER), High-Frequency Pasive Vibration (OTHER).

Who is sponsoring clinical trial NCT01841840?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01841840's enrollment target sits among peer trials

11 1927th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01841840, the US trial registry maintained by the National Library of Medicine. NCT01841840 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.